We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Weight-Loss Surgery Could Potentially Resolve Diabetes

By HospiMedica International staff writers
Posted on 24 Mar 2009
Bariatric surgery to reduce obesity could completely eliminate all manifestations of Type 2 diabetes, according to a new study.

Researchers at the University of Minnesota (Minneapolis, USA) analyzed 621 studies conducted between 1990 and April 2006, which included 135,246 patients. More...
In all, 3,188 patients reported resolution of the clinical and laboratory manifestations of type 2 diabetes. A further 19 studies with 11,175 patients reported both weight loss and diabetes resolution outcomes separately for the 4,070 diabetic patients in those studies. Clinical findings were substantiated by the laboratory parameters of serum insulin, HbA1c, and glucose. The study results showed that in all, an average of 78.1% of diabetic patients had complete resolution, and diabetes was improved or resolved in 86.6% of patients as the result of bariatric surgery. 82% of patients had resolution of the clinical and laboratory manifestations of diabetes in the first 2 years after surgery, and 62% remained free of diabetes more than 2 years after surgery (80% and 75% for the total group). The researchers observed a progressive relationship of diabetes resolution and weight loss as a function of the type of operation performed: laparoscopic adjustable gastric banding yielded 56.7% resolution, gastroplasty 79.7%, gastric bypass 80.3%, and biliopancreatic diversion/duodenal switch (BPD/DS) yielded 95.1% resolution of diabetes. After more than two years postoperative, the corresponding resolutions were 58.3%, 77.5%, 70.9%, and 95.9%. The study was published in the March 2009 issue of The American Journal of Medicine.

"This systematic review and meta-analysis demonstrate that bariatric surgery has a powerful treatment effect in morbidly obese persons with type 2 diabetes," said lead author Henry Buchwald, M.D., Ph.D., and colleagues of the department of surgery. "Randomized clinical trials comparing surgery and medical therapies for type 2 diabetes are urgently needed."

Related Links:

University of Minnesota



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.